Concepedia

John S. Driscoll

JS

64

Publications

3.1K

Citations

30

H-Index

1960

Active since

Affiliations

National Institutes of Health(Current)

National Cancer Institute

John S. Driscoll is an author at National Institutes of Health specializing in pharmacology, medicine, and medicinal chemistry.

Top concepts

PharmacologyMedicineDrug DiscoveryMedicinal ChemistryNatural SciencesBiochemistryOrganic ChemistryPharmacotherapyChemistryBioorganic Chemistry

Publications per year

1960–2000

64

Publications

64

A High Energy Density Lithium/Dichloroisocyanuric Acid Battery System

D.L. Williams, J. J. Byrne, John S. Driscoll · Journal of The Electrochemical Society · 1969 · 243 citations

Engineering, Chemistry, Chemical Engineering +17

Conformational changes of small molecules binding to proteins

Marc C. Nicklaus, Shaomeng Wang, John S. Driscoll et al. · Bioorganic & Medicinal Chemistry · 1995 · 229 citations

Protein Chemistry, Protein Assembly, Protein Folding +7

Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2‘,3‘-dideoxynucleoside analogs in resting and activated human cells.

Wei Gao, Riad Agbaria, John S. Driscoll et al. · Journal of Biological Chemistry · 1994 · 213 citations · Full text

Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV

Víctor E. Márquez, Christopher K. H. Tseng, Hiroaki Mitsuya et al. · Journal of Medicinal Chemistry · 1990 · 211 citations

Medicinal Chemistry, 2',3'-Dideoxy Purine Nucleosides, Biochemistry +14

Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1

Abdul Hameed Khan, John S. Driscoll · Journal of Medicinal Chemistry · 1976 · 153 citations

Medicinal Chemistry, Pharmaceutical Chemistry, 3,6-Substituted 2,5-Diaziridinyl-1,4-benzoquinones +11

Rows per page

1–5 of 64